Joseph A. Odin
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Liver Diseases and Immunity, Drug-Induced Hepatotoxicity and Protection, Liver Disease and Transplantation, Hepatitis C virus research
Most-Cited Works
- → Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study(2015)878 cited
- → Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease(2016)374 cited
- → International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways(2015)306 cited
- → Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites(2006)226 cited
- → Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis(2010)217 cited
- → Bcl-2–dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis(2001)186 cited
- → Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study(2017)182 cited
- → Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants(2012)156 cited
- → Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1(2004)151 cited